BiomX Receives NYSE American Acceptance of Compliance Plan Through September 2027

On June 10, 2026, BiomX Inc. received notice from NYSE Regulation that the exchange has accepted the Company’s compliance plan to regain compliance with continued listing standards. Previously, on March 25, 2026, the Company was notified of its failure to satisfy Sections 1003(a)(i), (ii), and (iii) of the NYSE American Company Guide due to a reported stockholders’ deficit of $(1.302 million) as of December 31, 2025, and net losses in its five most recent fiscal years. The NYSE has granted BiomX a plan period through September 25, 2027, to regain compliance. During this period, the Company’s common stock (PHGE) will continue to be listed and traded on the NYSE American, subject to periodic reviews of its progress against the initiatives outlined in the plan. While the stock remains listed, a '.BC' (below compliance) indicator will be appended to the ticker symbol. If the Company fails to meet the plan's milestones or regain compliance by the September 2027 deadline, NYSE Regulation may initiate delisting proceedings. BiomX stated it is committed to executing the plan but provided no assurance of a successful outcome.